t(4;11)(q21;q23) KMT2A/AFF1
2017-02-01 Rawan Faramand  , Rawan Faramand   Affiliation1.Moffitt Cancer Center, Tampa, FL (RF); Oncology and Hematology, Mercy Clinic Joplin, MO USA - [email protected] (SD)
2.Genetics, Dept Medical Information, University of Poitiers, CHU Poitiers Hospital, F-86021 Poitiers, France
Abstract
Review on t(4;11)(q21;q23) KMT2A/AFF1 with data on clinics and the genes involved.
Clinics and Pathology
Disease
Phenotype stem cell origin
Epidemiology
Clinics
Pathology
Treatment
In rare cases of t(4;11) AML, induction chemotherapy with antracycline based treatment is indicated followed by consolidation and allogenic bone marrow transplantation.
Prognosis
Cytogenetics

Additional anomalies
Variants
Genes Involved and Proteins
AFF1 is the AF4/FMR2 family member 1, also known as AF4.
Result of the Chromosomal Anomaly
Description
e.g. 2319 amino acids; 240 kDa; N-term AT hook and DNA methyltransferase from KMT2A fused to AFF1 C-term; the reciprocal ( AFF1/ KMT2A) may or may not be expressed; quite similar to the KMT2A/ MLLT1 fusion protein found with t(11;19)(q23;p13.3)
Expression localisation
Highly cited references
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 30478448 | 2019 | Targeting EIF4E signaling with ribavirin in infant acute lymphoblastic leukemia. | 108 |
| 41980221 | 2026 | 3D Chromosome Remodeling in B-cell Development and Acute Lymphoblastic Leukemia. | 103 |
| 34088716 | 2021 | A KMT2A-AFF1 gene regulatory network highlights the role of core transcription factors and reveals the regulatory logic of key downstream target genes. | 100 |
| 38822412 | 2024 | Sequential drug treatment targeting cell cycle and cell fate regulatory programs blocks non-genetic cancer evolution in acute lymphoblastic leukemia. | 100 |
| 32721124 | 2019 | The RS4;11 cell line as a model for leukaemia with t(4;11)(q21;q23): Revised characterisation of cytogenetic features. | 88 |
| 35800767 | 2022 | The immune checkpoint ICOSLG is a relapse-predicting biomarker and therapeutic target in infant t(4;11) acute lymphoblastic leukemia. | 83 |
| 40389585 | 2025 | Highly specific Immunoproteasome inhibitor M3258 induces proteotoxic stress and apoptosis in KMT2A::AFF1 driven acute lymphoblastic leukemia. | 80 |
| 39834944 | 2024 | Loss of SMAD1 in acute myeloid leukemia with KMT2A::AFF1 and KMT2A::MLLT3 fusion genes. | 72 |
| 40722046 | 2025 | HDAC7 induction combined with standard-of-care chemotherapy provides a therapeutic advantage in t(4;11) infant B-cell acute lymphoblastic leukemia. | 72 |
| 33895809 | 2021 | Molecular classification improves risk assessment in adult BCR-ABL1-negative B-ALL. | 70 |
| 38029383 | 2024 | Functional relevance of circRNA aberrant expression in pediatric acute leukemia with KMT2A::AFF1 fusion. | 68 |
| 37740239 | 2023 | Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia. | 68 |
| 40685918 | 2025 | Suppressing t(4;11) Acute Leukemia by Lipopolymer Nanoparticle Delivery of siRNA Targeting KMT2A::AFF1 with Enhanced Extrahepatic Delivery. | 67 |
| 32414848 | 2021 | Combinatorial efficacy of entospletinib and chemotherapy in patient-derived xenograft models of infant acute lymphoblastic leukemia. | 60 |
| 42038742 | 2026 | A microRNA expression signature in infant t(4;11) KMT2A::AFF1+ BCP-ALL uncovers novel therapeutic targets. | 60 |
| 30679323 | 2019 | Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis. | 60 |
| 37100882 | 2023 | The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome. | 57 |
| 42245927 | 2026 | FusionTarget: Computational framework for drug repurposing against modeled fusion protein structures from genomic breakpoints. | 56 |
| 40646135 | 2025 | Ontogeny-specific induction of the KMT2A::AFF1-fusion drives development of a distinct CD24 positive pre-leukemic state. | 55 |
| 40729681 | 2025 | Enhancer heterogeneity in acute lymphoblastic leukemia drives differential gene expression in patients. | 55 |
| 36595475 | 2023 | A comprehensive landscape of transcription profiles and data resources for human leukemia. | 53 |
| 33646306 | 2021 | Genome-wide interference of ZNF423 with B-lineage transcriptional circuitries in acute lymphoblastic leukemia. | 52 |
| 41145673 | 2026 | CRISPR/Cas9-mediated t(4;11) translocation in human hematopoietic stem/precursor cells demonstrates plasticity to differentiate into either the myeloid or lymphoid lineage. | 51 |
| 34575904 | 2021 | Genetic and Epigenetic Characterization of a Discordant KMT2A/AFF1-Rearranged Infant Monozygotic Twin Pair. | 49 |
| 41614752 | 2025 | Research Progress on the KMT2A-AFF3 Fusion Gene in Childhood Acute Lymphoblastic Leukemia: Mechanisms, Clinical Implications, and Therapeutic Strategies. | 46 |
| 34657128 | 2022 | Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study. | 45 |
| 36585787 | 2023 | Discovery of fusion circular RNAs in leukemia with KMT2A::AFF1 rearrangements by the new software CircFusion. | 45 |
| 37699001 | 2023 | Rapid detection of myeloid neoplasm fusions using single-molecule long-read sequencing. | 42 |
| 35685921 | 2022 | Low Prevalence of ETV6::RUNX1 Fusion Gene in a Hispanic Population. | 40 |
| 26648836 | 2015 | Cytogenetic and Molecular Findings in Children with Acute Lymphoblastic Leukemia: Experience of a Single Institution in Argentina. | 38 |
| 31807115 | 2019 | Clinical-biological characteristics and treatment outcomes of pediatric pro-B ALL patients enrolled in BCH-2003 and CCLG-2008 protocol: a study of 121 Chinese children. | 38 |
| 28076841 | 2017 | Clonal evolution in therapy-related neoplasms. | 36 |
| 33333966 | 2020 | Outcomes in Pediatric Acute Lymphoblastic Leukemia-A Single-Center Romanian Experience. | 36 |
| 38621200 | 2024 | Optimized cytogenetic risk-group stratification of KMT2A-rearranged pediatric acute myeloid leukemia. | 35 |
| 42223251 | 2026 | Central nervous system involvement and relapse in adult acute lymphoblastic leukaemia-a population-based analysis in 2007-2022. | 34 |
| 40936710 | 2025 | Expression of aberrant markers in monitoring of measurable residual disease in B-cell precursor acute lymphoblastic leukemia patients during remission-inducing therapy phase. | 33 |
| 41333696 | 2025 | Blinatumomab-Related Lineage Switch of KMT2A/AFF1-Rearranged B-Lymphoblastic Leukemia to B/Myeloid Mixed-Phenotype Acute Leukemia and Myeloid Sarcoma Causing Spinal Cord Compression. | 30 |
| 42851184 | 2026 | [KMT2A-rearranged acute lymphoblastic leukemia with lineage switch following relapse: a case report and literature review]. | 29 |
| 38435424 | 2024 | Enhanced potency of immunotherapy against B-cell precursor acute lymphoblastic leukemia by combination of an Fc-engineered CD19 antibody and CD47 blockade. | 25 |
| 39717192 | 2024 | Case Report: A case of infantile acute hyperleukocytic leukemia treated by leukapheresis. | 24 |
| 34525185 | 2021 | Outcomes of acute lymphoblastic leukemia with KMT2A (MLL) rearrangement: the MD Anderson experience. | 21 |
| 38650597 | 2024 | Proximally biased V(D)J recombination in the clonal evolution of IGH alleles in KMT2A::AFF1 BCP-ALL of all age classes. | 20 |
| 35933338 | 2022 | Poor treatment responses were related to poor outcomes in pediatric B cell acute lymphoblastic leukemia with KMT2A rearrangements. | 19 |
| 39917110 | 2025 | A Case of Childhood Acute Lymphoblastic Leukemia With Retinitis Pigmentosa-like Fundus Findings. | 16 |
| 42094197 | 2026 | Concurrent intracranial hemorrhage and spontaneous tumor Lysis syndrome as the initial presentation of KMT2A::AFF1-rearranged adult ALL: a case report. | 16 |
| 42960217 | 2026 | Refining risk in historically high-risk pediatric B-cell acute lymphoblastic leukemia: response kinetics and outcomes. | 16 |
| 31885955 | 2019 | Immunotherapy- (Blinatumomab-) Related Lineage Switch of KMT2A/AFF1 Rearranged B-Lymphoblastic Leukemia into Acute Myeloid Leukemia/Myeloid Sarcoma and Subsequently into B/Myeloid Mixed Phenotype Acute Leukemia. | 14 |
| 34930453 | 2021 | Daratumumab and venetoclax in combination with chemotherapy provide sustained molecular remission in relapsed/refractory CD19, CD20, and CD22 negative acute B lymphoblastic leukemia with KMT2A-AFF1 transcript. | 13 |
| 29016570 | 2017 | Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis. | 12 |
| 37917159 | 2024 | Genome editing-induced t(4;11) chromosomal translocations model B cell precursor acute lymphoblastic leukemias with KMT2A-AFF1 fusion. | 7 |
| 29806701 | 2018 | Neonatal leukaemia. | 0 |
| 34497221 | 2021 | [Acute leukemia of infants and neonates]. | 0 |
| 42610417 | 2026 | A novel KMT2A::AFF1-derived fusion circRNA regulates mitochondrial metabolism in t(4;11) B-cell acute lymphoblastic leukemia. | 0 |
| 28646023 | 2017 | Amlexanox Downregulates S100A6 to Sensitize KMT2A/AFF1-Positive Acute Lymphoblastic Leukemia to TNFα Treatment. | 0 |
| 37639801 | 2023 | Generation of a human induced pluripotent stem cell line harboring the infant leukemia-associated fusion gene, KMT2A-AFF1 (IMSUTi002-A-2). | 0 |
| 42242459 | 2026 | Inhibition of MLLT1 Limits Growth of KMT2A::AFF1 Leukemias Without Killing Healthy Hematopoietic Stem Cells. | 0 |
| 34349066 | 2021 | [Leukemogenic pathway of infant leukemia with MLL fusion]. | 0 |
| 35323988 | 2022 | TP53 loss‑of‑function mutations reduce sensitivity of acute leukaemia to the curaxin CBL0137. | 0 |
| 41053511 | 2025 | Combined treatment with amlexanox and cytarabine induces apoptosis via the S100A6-Akt pathway in KMT2A::AFF1-positive acute lymphoblastic leukemia. | 0 |
| 42213620 | 2026 | LIN28B is essential for human fetal B-lymphopoiesis and initiation of KMT2A::AFF1 infant leukemia. | 0 |
| 41027490 | 2026 | Upfront menin-inhibitor resistance in multiply pretreated leukemias. | 0 |
| 32114371 | 2020 | Osteopontin-c is overexpressed in KMT2A-AFF1 positive pediatric B-cell lymphoblastic leukemia when compared to those with ETV6-RUNX1". | 0 |
| 39672769 | 2025 | Next-generation sequencing RNA fusion panel for the diagnosis of haematological malignancies. | 0 |
| 30347268 | 2019 | Clinical Evaluation of Massively Parallel RNA Sequencing for Detecting Recurrent Gene Fusions in Hematologic Malignancies. | 0 |
| 34048072 | 2021 | Prognostic impact of KMT2A-AFF1-positivity in 926 BCR-ABL1-negative B-lineage acute lymphoblastic leukemia patients treated in GIMEMA clinical trials since 1996. | 0 |
| 41371538 | 2026 | Mixed-lineage leukemia cells undergo unique adaptations in the CNS niche. | 0 |
| 42537480 | 2026 | Influence of IGF2BP3 on t(4;11) fusion mRNA and protein abundance. | 0 |
| 38175441 | 2023 | Lineage switch of KMT2A-rearranged adult B-lineage acute lymphoblastic leukemia following bispecific T-cell engager and monoclonal antibody therapy. | 0 |
| 40762137 | 2025 | HOX11 gene overexpression is associated with recurrence of acute B lymphoblastic leukaemia. | 0 |
| 42139054 | 2026 | miR-93-mediated PTEN suppression and CNS-specific T cell exhaustion shape the leukemia niche in infant KMT2A::AFF1+ B-ALL. | 0 |
| 26403224 | 2015 | HMGA2 as a potential molecular target in KMT2A-AFF1-positive infant acute lymphoblastic leukaemia. | 0 |
| 38096462 | 2024 | Four Additional Doses of PEG-L-Asparaginase During the Consolidation Phase in the AIEOP-BFM ALL 2009 Protocol Do Not Improve Outcome and Increase Toxicity in High-Risk ALL: Results of a Randomized Study. | 0 |
| 40037847 | 2025 | Cryptic Rearrangement of the KMT2A Gene in a B-cell Acute Lymphoblastic Leukemia. | 0 |
| 30872272 | 2019 | Mixed-phenotype acute leukemia with t(4;11)(q21;q23) KMT2A-AFF1-rearranged. | 0 |
| 30125757 | 2018 | Retrospective analysis of 36 fusion genes in 2479 Chinese patients of de novo acute lymphoblastic leukemia. | 0 |
| 37340822 | 2023 | Kiss of death between CAR-T cells and KMT2a::AFF1 B lymphoblasts in the central nervous system. | 0 |
| 40899517 | 2026 | Application of Targeted RNA-Sequencing in High-Risk B-Cell Acute Lymphoblastic Leukemia (B-ALL): Identifying Fusions, IKZF1 Deletions, and CRLF2 Expression in an Indian Cohort. | 0 |
| 41106102 | 2026 | Flexible electrochemical biochip for multianalyte detection in childhood leukemia diagnosis. | 0 |
| 40916596 | 2025 | Lineage switch of B-lymphoblastic leukemia with KMT2A::AFF1 fusion into acute myelomonocytic leukemia under blinatumomab therapy. | 0 |
| 28790105 | 2017 | Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia. | 0 |
| 28624474 | 2017 | "Exposure to the insecticides permethrin and malathion induces leukemia and lymphoma-associated gene aberrations in vitro". | 0 |
| 30203571 | 2018 | KMT2A (MLL) rearrangements observed in pediatric/young adult T-lymphoblastic leukemia/lymphoma: A 10-year review from a single cytogenetic laboratory. | 0 |
| 41351321 | 2026 | Acute Myeloid Leukemia With KMT2A Rearrangement Presenting as Skin Hyperpigmentation. | 0 |
| 41918382 | 2026 | [Analysis of ten cases of Acute lymphoblastic leukemia with non-KMT2A::AFF1 transcriptional variant 11q23 rearrangements]. | 0 |
| 30701458 | 2019 | Molecular profiling of adult acute myeloid and lymphoid leukemia in a major referral center in Lebanon: a 10-year experience report and review of the literature. | 0 |
| 40186692 | 2025 | Effective Utilization of a Customized Targeted Hybrid Capture RNA Sequencing in the Routine Molecular Categorization of Adolescent and Adult B-Lineage Acute Lymphoblastic Leukemia: A Real-World Experience. | 0 |
| 41759887 | 2026 | Gremlin-1 promotes leukemic survival via PI3K/AKT signaling in infant MLL-AF4-positive B-cell acute lymphoblastic leukemia. | 0 |
| 32992102 | 2020 | First report of t(5;11) KMT2A-MAML1 fusion in de novo infant acute lymphoblastic leukemia. | 0 |
| 33542481 | 2021 | Allogeneic hematopoietic stem cell transplantation for adult patients with t(4;11)(q21;q23) KMT2A/AFF1 B-cell precursor acute lymphoblastic leukemia in first complete remission: impact of pretransplant measurable residual disease (MRD) status. An analysis from the Acute Leukemia Working Party of the EBMT. | 0 |
| 40879568 | 2025 | Multiple Lineage Switches in a Pediatric Case With a KMT2A::AFF1-Positive Acute Lymphoblastic Leukemia: How Cell Plasticity Induces Immunotherapy Failure. | 0 |
| 40000924 | 2025 | Genetic Diversity in KMT2A -r and KMT2A -Wt Groups: Assessing the Prognostic Value of Markers in BCP-ALL Among Infants. | 0 |
| 28332262 | 2017 | Haploidentical peripheral blood stem cell transplantation without irradiation or busulfan after reduced-intensity conditioning for KMT2A(MLL)-rearranged infant B-cell precursor acute lymphoblastic leukemia: Report of two cases. | 0 |
Bibliography
No bibliography items were found for this article.
Summary
Fusion gene

Citation
Rawan Faramand ; Rawan Faramand
t(4;11)(q21;q23) KMT2A/AFF1
Atlas Genet Cytogenet Oncol Haematol. 2017-02-01
Online version: http://atlasgeneticsoncology.org/haematological/1051/t(4
Historical Card
1997-12-01 t(4;11)(q21;q23) KMT2A/AFF1 by Jean-Loup Huret,Jean-Loup Huret  Affiliation
